Skip to content

Whey Protein Supplementation and Serum Mineral Status in Elite Endurance and Power Athletes

Whey Protein Supplementation and Serum Mineral Status in Elite Endurance and Power Athletes: A Two-Month Non-Randomized Open-Label Intervention Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07488273
Enrollment
59
Registered
2026-03-23
Start date
2026-02-25
Completion date
2026-03-15
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletic Performance

Keywords

Athletic Performance, Mineral Homeostasis

Brief summary

This study investigates whether 8 weeks of post-training whey protein supplementation (30 g/day) affects serum mineral concentrations (calcium, phosphorus, magnesium, and iron) in elite endurance and power athletes during structured training.

Detailed description

This is a 10-week non-randomized, open-label intervention study involving elite male track-and-field athletes aged 18-26 years. Participants are allocated into a whey protein supplementation group or a control group based on convenience allocation. The intervention consists of daily intake of 30 g whey protein following training sessions over 8 weeks. Blood samples are collected at baseline and post-intervention to assess serum calcium, phosphorus, magnesium, and iron levels. The study aims to differentiate supplementation effects from training-induced physiological changes.

Interventions

Participants in the intervention group consumed 30 g/day of whey protein powder within 30 minutes after training sessions for 8 weeks as part of a structured training program. The supplement (IronMaxx®, 100% Whey Protein) primarily consisted of whey protein concentrate and provided approximately 24 g of protein per daily dose. The intervention was administered in an open-label manner without placebo control. Participants were instructed to maintain their habitual diet and refrain from using additional nutritional supplements during the study period.

OTHERNo Supplement (Control)

Participants continued their usual sport-specific training program for 8 weeks without receiving whey protein or any additional nutritional supplementation. They were instructed to maintain their habitual diet and avoid initiating any new supplements during the study period.

Sponsors

Monira Aldhahi
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants are divided into whey supplementation and control groups within endurance and power disciplines, with no randomization or blinding.

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Male elite track-and-field athletes * Age 18-30 years * Engaged in structured training program * No supplement use in past 3 months

Exclusion criteria

* Use of nutritional or mineral supplements * Metabolic or musculoskeletal disorders * Acute injury affecting performance * Use of ergogenic aids (e.g., creatine, anabolic agents)

Design outcomes

Primary

MeasureTime frameDescription
serum mineral concentrations (Calcium, Phosphorus, Magnesium, Iron)Baseline (Week 1) and Post-Intervention (Week 10)Serum concentrations of calcium, phosphorus, magnesium, and iron will be measured using standardized enzymatic and colorimetric assays from venous blood samples collected at rest. Measurements will be performed at baseline and after the intervention to assess changes associated with training and whey protein supplementation in elite athletes.

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026